Metabasis Therapeutics (MBRX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Metabasis Therapeutics (MBRX)

MBRX 0.451

-4.8%

Oct 30 3:59 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: rkrw who wrote (55)	7/17/2007 5:49:05 PM
From: tuck	Read Replies (1) of 66

Too cynical? They're throwing out low baseline levels as an excuse, but to my knowledge they never told us the patients studied in the 2b would have significantly different baseline characteristics from those in the 2a. I probably would have run the other way if I'd known that. 2a results: professional.diabetes.org 2b protocol: clinicaltrials.gov I can't find the protocol for the 2a. The box for searching for trials that are no longer recruiting is greyed out. When I check it, I get nothing. I agree it won't cost much to look. I'm just afraid they'll find something spurious and chase after it. A conspiracy theorist might say Daiichi sabotaged the trial by allowing the patient population they did. As you noted, they are both partner and competitor. sankyopharma.com It wouldn't shock me if the Lerach crowd jumps on this. Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next